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Trex1, a major 3′ DNA exonuclease in mammalian cells, has been thought to act primarily in 
DNA replication or repair. Surprisingly, the major phenotype resulting from Trex1 deficiency 
in humans and mice is a chronic inflammatory disease. In this issue, Yang et al. (2007) 
report that Trex1 deficiency causes chronic activation of the ATM-dependent DNA-damage 
checkpoint and accumulation of a discrete single-stranded DNA species in the cytoplasm, 
either of which could contribute to chronic inflammation.Studies of DNA damage and DNA 
repair have recently yielded several 
intriguing connections to the immune 
response. To this we can add excit-
ing recent findings that mutations in 
Trex1, the major 3′ DNA exonuclease 
in cells, cause inflammatory myocardi-
tis in mice and a complex disease in 
humans called Aicardi-Goutières syn-
drome (AGS), which is characterized 
in part by an autoimmune syndrome 
similar to systemic lupus erythemato-
sus (SLE) (Crow et al., 2006). Just a 
few years ago, there would have been 
few candidate mechanisms to link a 
DNA-processing enzyme to immu-
nity, but it is testimony to the pace 
of recent discoveries that numerous 
possibilities can now be considered 
(Figure 1).
A study by Yang et al. (2007) in this 
issue adds two intriguing new angles 
to this emerging story. First, the 
authors demonstrate that Trex1 defi-
ciency results in constitutive activation 
of the ATM-dependent DNA-damage 
checkpoint, as indicated by desta-
bilization of Chk2, a key transducer 
kinase in the pathway, and increased 
levels of the tumor suppressor p53 
and the downstream CDK inhibitor 
p21. As a result, Trex1-deficient fibro-
blasts are impaired in the G1/S phase 
transition. Second, in cells lacking 
Trex a discrete single-stranded DNA 
(ssDNA) species of 60–65 bases 
was found to accumulate in the cyto-
plasm, where Trex normally resides. 836 Cell 131, November 30, 2007 ©2007 The origin of this DNA species and 
whether it is responsible for activat-
ing the DNA-damage checkpoint 
remain to be definitively established. 
Equally unclear is whether either the 
DNA species or the activation of the 
DNA-damage checkpoint are respon-
sible for the autoimmunity observed 
in Trex1-deficient animals. Yet there Elsevier Inc.are precedents suggesting both as 
possibilities.
Recent studies have drawn a con-
nection between the DNA-damage 
response, tumorigenesis, and the 
innate immune response. Activation of 
the DNA-damage response by geno-
toxic agents, or the constitutive acti-
vation observed in many tumor cell Figure 1. Inflammatory Disease and Trex1 Deficiency
Multiple mechanisms could account for the inflammatory disease in mice caused by Trex1 defi-
ciency. Trex1 deficiency leads to the chronic activation of the cell-cycle checkpoint kinase ATM, 
which could induce expression of ligands that stimulate natural killer (NK) cells or T cells or 
could disturb T cell development thus interfering with the process that ensures lymphocyte self-
tolerance. Lymphocyte self-tolerance might also be impaired in Trex1 mutant animals as a result 
of defective function of the Trex1- and granzyme-dependent SET complex. Alternatively, Trex1 
may normally function in host defense to counter infection with DNA viruses or endogenous 
retroviruses, such that Trex1 deficiency leads to chronic activation of DNA-sensing receptors of 
the innate immune system.
lines, induces cell-surface expression 
of ligands that engage the NKG2D 
stimulatory receptor expressed by 
natural killer (NK) cells and certain T 
cell populations (Gasser et al., 2005). 
Because the DNA-damage response 
is activated early during the pro-
cess of tumorigenesis, it has been 
proposed that induction of NKG2D 
ligands may serve as a barrier to tum-
origenesis. NKG2D engagement by its 
ligands activates NK cells and T cells 
to kill target cells that express NKG2D 
ligands and to secrete inflammatory 
cytokines that may limit tumor devel-
opment. Cytokine secretion could 
also underlie inflammatory disorders 
in cases where NKG2D ligands are 
inappropriately expressed. Interest-
ingly, expression of NKG2D ligands 
by inflamed tissue and the NKG2D-
dependent activation of immune cells 
that results have been linked to sev-
eral chronic inflammatory diseases, 
such as rheumatoid arthritis, celiac 
disease, and type I diabetes (Oga-
sawara and Lanier, 2005). Thus, it is 
plausible that chronic activation of 
the DNA-damage response in Trex1-
deficient cells causes inflammation 
by inducing expression of NKG2D 
ligands or other activators of the 
immune system. This possibility could 
be addressed by determining whether 
NKG2D function is necessary for dis-
ease in Trex1-deficient mice.
Our immune system encodes recep-
tors that recognize specific microbial 
features (Akira et al., 2006). Some of 
these host receptors recognize viral 
RNA or DNA and are localized in the 
cytoplasm. Activation of these recep-
tors, including a recently described 
DNA sensor called DAI (Takaoka et 
al., 2007), leads to the transcription 
of many genes, such as the antiviral 
cytokines known as type I interfer-
ons. Other receptors are localized 
either at the plasma membrane or in 
endosomes and sample the extracel-
lular milieu for the presence of patho-
gens. One example is Toll-like recep-
tor 9 (TLR9), an endosomal protein 
that recognizes unmethylated CpG 
motifs, a feature abundant in micro-
bial genomes but also represented 
in mammalian DNA. TLR9 can bind 
pathogen DNA in endosomes after pathogens are engulfed and partially 
degraded. Interestingly, it has been 
recently suggested that endosomal 
TLRs might also sample the intracel-
lular milieu through autophagy. In this 
case, nucleic acids in the cytosol are 
engulfed into autophagosomes, vesi-
cles capable of fusing with TLR-con-
taining endosomes (Lee et al., 2007).
Self-DNA is normally restricted to 
the nucleus or the mitochondria, away 
from the DNA sensors. However, this 
is not the case under some patho-
logical conditions, where activation 
of DNA sensors can be triggered in 
the absence of infection, leading 
to immune-associated pathology. 
Indeed, this is thought to occur in 
SLE, an autoimmune disease char-
acterized by the presence of immune 
stimulatory complexes consisting 
of autoantibodies bound to DNA or 
to nucleic acid-protein complexes. 
Uptake of these immune complexes 
by dendritic cells and trafficking of 
the associated nucleic acid to TLR-
containing endosomes is thought 
to amplify the disease by provoking 
secretion of type I interferons (Bac-
cala et al., 2007).
The inflammatory syndrome associ-
ated with Trex1 deficiency or observed 
in AGS patients is associated with 
elevated levels of type I interferons 
and accumulation of a ssDNA species 
in the cytoplasm. Mislocalization of 
nucleic acids to the cytoplasm or the 
extracellular milieu is thought to trigger 
antiviral immune responses and could 
be the culprit in causing the inflamma-
tory disease in Trex1-deficient mice 
and AGS patients. Experiments test-
ing whether these ssDNA molecules 
are subject to autophagy (for potential 
presentation to TLR9) or whether the 
known intracellular DNA sensors are 
activated in fibroblasts lacking Trex1 
might be highly informative.
Yang et al. (2007) attribute the 
ssDNA species seen in Trex1-de-
ficient cells to byproducts of DNA 
replication, but there are other pro-
cesses that might be involved in 
generating ssDNAs that are normally 
degraded by Trex1. Trex1 is known to 
be a component of the SET complex, 
which includes the NM23-H1 endo-
nuclease. NM23-H1 cooperates with Cell 131, Novthe 3′ exonuclease activity of Trex1 
to destroy nicked double-stranded 
DNA (Chowdhury et al., 2006). The 
SET complex is implicated in apop-
tosis mediated by granzyme A, but 
it may have other functions in host 
defense. Thus, Trex1 may be part of a 
complex that counters DNA viruses, 
or viruses with DNA intermediates, 
including endogenous retroviruses. 
Most endogenous retroviruses, which 
account for nearly 10% of the mam-
malian genome, have lost replica-
tion competence due to inactivating 
mutations, but several are still active. 
As part of their replicative strategy, 
they generate a DNA intermediate in 
the cytosol of their host cell. Trex1 
might function as part of the cellular 
machinery that degrades these inter-
mediates. Incomplete degradation of 
such intermediates might result in the 
accumulation of the observed ssDNA 
species in Trex1-deficient cells.
The role of Trex1 in granzyme 
A-mediated cell death suggests yet 
another mechanism underlying auto-
immunity in Trex1-deficient animals. 
Granzyme A, along with perforin and 
other granzymes, is a component of 
cytotoxic granules released by cyto-
toxic T cells and NK cells. Defects 
in perforin- or granzyme-dependent 
cytotoxicity—as seen in perforin-
deficient mice and patients with a 
disease called familial hemophago-
cytic lymphohistiocytosis—are also 
associated with autoimmunity (Janka, 
2007). This may reflect the inability of 
mice to eliminate potentially autore-
active lymphocytes. Defective gran-
zyme A action as a result of Trex1 
deficiency could similarly result in 
autoimmunity.
Finally, the chronic activation of the 
ATM protein (a cell-cycle checkpoint 
kinase) in cells lacking Trex could 
promote autoimmunity by impact-
ing lymphocyte development. The 
ATM gene was originally identified as 
the gene mutated in ataxia telangi-
ectasia, a disease characterized 
by immune deficiency, progressive 
neurodegeneration, and sensitivity 
to irradiation. ATM-deficient mice, 
which exhibit a similar disorder, have 
partially impaired T cell development, 
owing to defects in the V-J recombi-ember 30, 2007 ©2007 Elsevier Inc. 837
nation process (Vacchio et al., 2007). 
Thus, the chronic inflammatory phe-
notype of Trex1-deficient mice could 
be the result of alterations in T cell 
development resulting in impaired 
function of the T cells that regulate 
self-tolerance in the immune system. 
Chimera experiments to test whether 
the immune phenotype of Trex1-defi-
cient mice is intrinsic to lymphocytes 
would be helpful in evaluating this 
and other related possibilities.
Thus, there are a startling number of 
ways that a defect in a DNA-process-
ing enzyme could impact the immune 
response. It is particularly compel-
ling that Trex1-deficient animals show 
no increase in mutation frequency or 
cancer incidence. This finding under-838 Cell 131, November 30, 2007 ©2007
DNA damage leads to the activation 
of a DNA-damage checkpoint that 
halts cell-cycle progression and 
alters DNA replication and repair to 
maintain genome stability (Kastan 
and Bartek, 2004). In general, DNA 
damage is initially detected by 
checkpoint proteins that once acti-
vated modify other proteins involved 
in either cell-cycle progression 
or DNA repair or replication itself. 
However, many molecular pathways 
connecting checkpoint proteins 
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sion remain largely unresolve
suggest that tRNA trafficking a
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G1 to S phase transition.scores the possibility that the primary 
biological role of Trex1 lies not in DNA 
repair but in the regulation of immu-
nity. It will be fascinating to see how 
the story resolves.
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